Screener
Revolution Medicines, Inc. RVMD Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s return on invested capital?
- Revolution Medicines, Inc. (RVMD) reported return on invested capital of -89.6% in Q1 2026.
- How has Revolution Medicines, Inc.'s return on invested capital changed year-over-year?
- Revolution Medicines, Inc.'s return on invested capital decreased by 93.2% year-over-year, from -46.4% to -89.6%.
- What is the long-term trend for Revolution Medicines, Inc.'s return on invested capital?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s return on invested capital has grown at a 16.7% compound annual growth rate (CAGR), from -39% to -72.4%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Revolution Medicines, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude